Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Edwards Lifesciences (NY: EW )

71.27 +0.79 (+1.12%)
Official Closing Price Updated: 4:10 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
15 16 Next >
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years
Via Benzinga
Peering Into Edwards Lifesciences's Recent Short Interest
Via Benzinga
Analyst Ratings for Edwards Lifesciences
Via Benzinga
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 10 Years
Via Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $7,400 Today
Via Benzinga
Illumina Takes AI to Genomics: Launch of PrimateAI-3D for Accurate Disease Prediction
Illumina, Inc. (NASDAQ: ILMN) launched PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts disease-causing genetic mutations in patients. 
Via Benzinga
The Latest Analyst Ratings for Edwards Lifesciences
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $800 Today
Via Benzinga
Will Investors Notice Exciting Sign On Edwards Lifesciences's Chart?
Via Benzinga
Here's How Much $1000 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth Today
Via Benzinga
Piper Sandler Maintains Neutral Rating for Edwards Lifesciences: Here's What You Need To Know
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
3 Medical Device Stocks Outpacing the Healthcare Industry This Year
All three of these companies have seen double-digit increases in their share prices this year. 
Via The Motley Fool
Market Rally Wobbles Amid Big Earnings Moves From Microsoft, Meta, Crocs, Cloudflare: Weekly Review
Microsoft, Meta, Cloudflare and Crocs were among the many big movers. 
Via Investor's Business Daily
This Is What Whales Are Betting On Edwards Lifesciences
Via Benzinga
The Latest Analyst Ratings for Edwards Lifesciences
Via Benzinga
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 5 Years
Via Benzinga
The Latest Analyst Ratings for Edwards Lifesciences
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
eBay To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Tuesday
B of A Securities cut the price target for Catalent, Inc. (NYSE: CTLT) from $78 to $49. B of A Securities analyst Derik De Bruin maintained a Neutral rating. Catalent shares fell 0.2% to $44.83 in... 
Via Benzinga
3 No-Brainer Medical Device Stocks to Buy Right Now
These companies have consistently delivered revenue and EPS gains. 
Via The Motley Fool
Looking Into Edwards Lifesciences's Recent Short Interest
Via Benzinga
Expert Ratings for Edwards Lifesciences
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2023
Via Benzinga
Interview With David Rolfe of Wedgewood Partners
Motley Fool analyst John Rotonti recently seized the opportunity to interview David Rolfe. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023
Via Benzinga
Buy/Sell: Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 4
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street’s best analysts during the week of Jan. 30 through Feb. 3. 
Via Talk Markets
Edwards Lifesciences Q4 Earnings Beats Street Estimates, Expects Easing Of Macro Headwinds Later In 2023
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.